http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#head http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#assertion http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#provenance http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#publicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#assertion http://bio2rdf.org/drugbank:DB01186 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://bio2rdf.org/drugbank:DB08920 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://purl.org/dc/terms/identifier drugbank_resource:DB01186_DB08920 http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://purl.org/dc/terms/title DDI between Pergolide and Zuclopenthixol decanoate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and pergolide, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. Pergolide, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if pergolide is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01186_DB08920 http://www.w3.org/2000/01/rdf-schema#label DDI between Pergolide and Zuclopenthixol decanoate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and pergolide, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. Pergolide, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if pergolide is initiated, discontinued or dose changed. [drugbank_resource:DB01186_DB08920] http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#provenance http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#publicationInfo http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#signature.MCwCFGiCX2wppE6e http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#signature.MCwCFGiCX2wppE6e http://purl.org/nanopub/x/hasSignature MCwCFGiCX2wppE6eTTV5PXNIoAm84Tr9AhQacNu7ZyIr8fsOSQHfNki50WmiNQ== http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#signature.MCwCFGiCX2wppE6e http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://purl.org/dc/terms/created 2018-03-30T11:12:51.567+02:00 http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w#signature.MCwCFGiCX2wppE6e http://bio2rdf.org/drugbank_resource:DB01186_DB08920_nanopub.RAo1REZIDt-9mZvozF_ZEYRX3zOhHXdMFO-LHtPJpTV6w http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234